Cardlytics, Inc. operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. It also provides solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded in 2008 and is headquartered in Atlanta, Georgia.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Computer programming, data processing, & other computer related
Sub-IndustryN/A
SectorBusiness Services
SymbolNASDAQ:CDLX
CUSIPN/A
Phone888-798-5802
Debt
Debt-to-Equity Ratio0.81
Current Ratio1.68
Quick Ratio1.68
Price-To-Earnings
Trailing P/E Ratio-2.58
Forward P/E Ratio-10.51
P/E GrowthN/A
Sales & Book Value
Annual Sales$130.37 million
Price / Sales3.22
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees342
Outstanding Shares20,260,000
Market Cap$421.90
Cardlytics (NASDAQ:CDLX) Frequently Asked Questions
What is Cardlytics' stock symbol?
Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."
How were Cardlytics' earnings last quarter?
Cardlytics Inc (NASDAQ:CDLX) issued its earnings results on Thursday, May, 10th. The company reported ($0.60) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.62) by $0.02. The business had revenue of $32.71 million for the quarter, compared to the consensus estimate of $29.74 million. View Cardlytics' Earnings History.
What price target have analysts set for CDLX?
6 analysts have issued 1 year price objectives for Cardlytics' shares. Their forecasts range from $19.00 to $25.00. On average, they expect Cardlytics' share price to reach $22.40 in the next twelve months. This suggests a possible upside of 8.1% from the stock's current price. View Analyst Ratings for Cardlytics.
What is the consensus analysts' recommendation for Cardlytics?
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
Who are some of Cardlytics' key competitors?
Some companies that are related to Cardlytics include 21Vianet Group (VNET), TrueCar (TRUE), HealthStream (HSTM), Jianpu Technology (JT), Internet Initiative Japan (IIJI), Model N (MODN), Internap (INAP), The Rubicon Project (RUBI), Sify Technologies (SIFY), Synacor (SYNC), Edgewater Technology (EDGW), Autoweb (AUTO), Chinanet Online (CNET), GigaMedia (GIGM) and MassRoots (MSRT).
Who are Cardlytics' key executives?
Cardlytics' management team includes the folowing people:
- Mr. Scott D. Grimes, Co-Founder, CEO & Director (Age 55)
- Ms. Lynne Marie Laube, Co-Founder, COO & Director (Age 49)
- Mr. David Evans, CFO & Head of Corp. Devel.
- Mr. Sathish Gaddipati, Chief Technology Officer (Age 51)
- Mr. Kirk L. Somers, Chief Legal & Privacy Officer (Age 53)
When did Cardlytics IPO?
(CDLX) raised $76 million in an IPO on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.
When does Cardlytics' lock-up period expire?
Cardlytics' lock-up period expires on Wednesday, August 8th. Cardlytics had issued 5,400,000 shares in its initial public offering on February 9th. The total size of the offering was $70,200,000 based on an initial share price of $13.00. After the expiration of Cardlytics' lock-up period, company insiders and major shareholders will be able to sell their shares of the company.
Has Cardlytics been receiving favorable news coverage?
Media coverage about CDLX stock has been trending somewhat positive recently, Accern Sentiment reports. The research group identifies negative and positive press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cardlytics earned a news sentiment score of 0.13 on Accern's scale. They also gave news headlines about the company an impact score of 46.67 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.
How do I buy shares of Cardlytics?
Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cardlytics' stock price today?
One share of CDLX stock can currently be purchased for approximately $20.73.
How big of a company is Cardlytics?
Cardlytics has a market capitalization of $421.90 million and generates $130.37 million in revenue each year. The company earns $-19,640,000.00 in net income (profit) each year or ($8.02) on an earnings per share basis. Cardlytics employs 342 workers across the globe.
How can I contact Cardlytics?
Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected]
MarketBeat Community Rating for Cardlytics (NASDAQ CDLX)
MarketBeat's community ratings are surveys of what our community members think about Cardlytics and other stocks. Vote "Outperform" if you believe CDLX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CDLX will underperform the S&P 500 over the long term. You may vote once every thirty days.
